default author photo

Xiaofeng Ding

Hunan Normal University - The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development

China

SCHOLARLY PAPERS

1

DOWNLOADS

48

TOTAL CITATIONS

5

Scholarly Papers (1)

1.

Targeting KCTD1 as a Potential Novel Therapy Ameliorates Hepatocellular Carcinoma Progression via the HIF-1α/VEGF Pathway

Number of pages: 35 Posted: 01 Mar 2022
Hunan Normal University - The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, Hunan Normal University - The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, Hunan Normal University - The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, Hunan Normal University - College of Engineering and Design, Hunan Normal University - The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, Hunan Normal University - The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, Central South University - Department of Neurosurgery, Central South University - Department of Hepatobiliary and Pancreatic Surgery, City University of Hong Kong (CityU) - Department of Physics, Hunan Normal University - The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, Hunan Normal University - The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, Hunan Normal University - The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, Hunan Normal University - The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development and Hunan Normal University - The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development
Downloads 48 (1,086,013)
Citation 5

Abstract:

Loading...

KCTD1, hepatocellular carcinoma, HIF-1α, sorafenib, exosome